• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of bmcbioiBioMed Centralsearchsubmit a manuscriptregisterthis articleBMC Bioinformatics
BMC Bioinformatics. 2010; 11: 36.
Published online Jan 19, 2010. doi:  10.1186/1471-2105-11-36
PMCID: PMC2832896

Quantitative model for inferring dynamic regulation of the tumour suppressor gene p53



The availability of various "omics" datasets creates a prospect of performing the study of genome-wide genetic regulatory networks. However, one of the major challenges of using mathematical models to infer genetic regulation from microarray datasets is the lack of information for protein concentrations and activities. Most of the previous researches were based on an assumption that the mRNA levels of a gene are consistent with its protein activities, though it is not always the case. Therefore, a more sophisticated modelling framework together with the corresponding inference methods is needed to accurately estimate genetic regulation from "omics" datasets.


This work developed a novel approach, which is based on a nonlinear mathematical model, to infer genetic regulation from microarray gene expression data. By using the p53 network as a test system, we used the nonlinear model to estimate the activities of transcription factor (TF) p53 from the expression levels of its target genes, and to identify the activation/inhibition status of p53 to its target genes. The predicted top 317 putative p53 target genes were supported by DNA sequence analysis. A comparison between our prediction and the other published predictions of p53 targets suggests that most of putative p53 targets may share a common depleted or enriched sequence signal on their upstream non-coding region.


The proposed quantitative model can not only be used to infer the regulatory relationship between TF and its down-stream genes, but also be applied to estimate the protein activities of TF from the expression levels of its target genes.


Transcription of genes is generally controlled by a regulatory region of DNA located mostly up-stream of the gene transcription start site. This regulatory region contains a short sequence that the regulatory proteins bind to in order to enhance/inhibit the gene expression [1]. Current advance in high-throughput technologies such as DNA microarrays, together with the availability of whole genome sequence for several species, enable us to study the genome-wide genetic regulatory networks. These heterogeneous functional genomic datasets have been used to acquire, catalogue and infer genetic regulatory networks in a "top-down" fashion. It focuses on the reverse-engineering of genetic networks by identifying the regulatory interactions, inferring the transcriptional modules and predicting the combinatorial regulation of transcriptional factors (TFs) [2-5]. On the contrary, another principal research method, namely the "bottom-up" approach, builds detailed mathematical models for small-scaled genetic regulatory networks based on extensive experimental observations. To accomplish that goal, various types of models have been proposed to describe the genetic regulation. These models include, for example, differential equation models with continuous-time and continuous-variables, Bayesian network models with discrete-time and continuous-variables and Boolean network models with discrete-time and discrete-variables. Particularly, many differential equation models (e.g. linear systems, neural networks, S-systems and nonlinear models) have been used to investigate the dynamic properties of genetic regulation [6-9].

One of the major challenges of using a "bottom-up" approach to infer genetic regulation from microarray datasets is the lack of information for protein concentrations and activities. Most of the previous researches were based on the assumption that the expression levels of a gene are consistent with its protein activities, though we know that is not always the case. An earlier practice to rectify above assumption is a hidden variable dynamic modelling (HVDM) method, which is a linear dynamic model designed to estimate the activities of a TF by using the expression activities of its target genes [10]. Later, the HVDM method was extended to a nonlinear one by using the Michaelis-Menten function [11]. In addition, mathematical models with time delay were also used to elucidate the time difference between the activities of TFs and the expression profiles of target genes [12,13]. Nevertheless, a more sophisticated inference method, which considers both the time delay and protein-DNA binding structure, is needed to accurately describe the genetic regulation in a "bottom-up" fashion. The development of such methods still remains as one of the major challenges in the computational study of genetic regulatory networks by the integration of "omics" datasets and experimental results [14,15].

In earlier works, several "bottom-up" researches used the "master" gene networks to validate their proposed inference methodologies, as well as to investigate the regulatory function of the "master" gene [9,10]. Among them, tumour suppressor gene p53 has been described as "the guardian of the genome" highlighting its role in conserving stability by preventing genome mutation. Since a point mutation within the p53 gene occurs in over half of all human tumours, an elucidation of the regulatory mechanisms of p53 gene will contribute tremendously to the development of strategies for treating cancer [16]. Although many experimental methods have been employed to identify the transcriptional target genes of p53 (e.g. the clustering analysis of microarray data [17], protein expression profiles [18] and Chip-PET identification of transcriptional-factor binding sites [19]), it is imperative to develop more sophisticated mathematical models that precisely describe the p53 regulation. In this work, we propose a nonlinear differential equation model, which considers both the protein-DNA binding structure and the effect of time delay, to infer genetic regulation from microarray gene expression datasets. The proposed method is then applied to predict the p53 target genes.


Microarray data analysis

Preprocessing of raw microarray data

By using a previously published dataset [10], we selected 1,312 probes (e.g. the top 15% of the most responsive to the p53 activation, [Additional file 1]) from the preprocessed microarray dataset (~8,737 probes) by using the pair-wise Fisher's linear discriminant method [20]. To assess the robustness of such selection, we compared the gene selections between the pair-wise Fisher's linear discriminant method and the maSigPro method [21]. The maSigPro method is an R package especially designed for analyzing time-course microarray experiments, which was applied to the same preprocessed microarray dataset. The parameter settings of the maSigPro method are a false discovery value (Q) that equals to 0.05 and an R-squared threshold (R) whose value ranges from 0.3 to 0.9. Table Table11 suggests that both methods converged when a higher R-squared threshold (e.g. R > 0.5 represents a good model fitting in the original paper of the maSigPro method [21]) is used. Particularly, with a higher R-squared threshold, genes provided by the maSigPro method overlap more (> 85%) with that selected by the Fisher's method. Thus, the defined top 15% of the most relevant response probes is considered to be a robust selection.

Table 1
A comparison of significantly differential gene selections between the pair-wise Fisher's linear discriminant method and maSigPro method.

Clustering analysis

Consequently, the selected 1,312 probes were assigned to 40 co-expressed gene modules by using a published computational approach [5,20] that combines the stress function, neuron gas algorithm and K-nearest neighbour method. Each gene module represents a set of co-expressed genes that are stimulated by either a specific experimental condition or a common trans-regulatory input. From a functional analysis of the 40 gene modules, we found that the co-expressed gene modules might contain genes with either heterogeneous or homogeneous biological functions, which are irrelevant to the number of genes in each module. Rather, it may reflect the complex mechanisms that control the transcription regulation. Therefore, in the subsequent analysis, we applied our nonlinear dynamic model on the profile of each individual gene instead of the mean centre of each gene module. Detailed information of 1,312 probes and the corresponding 40 co-expressed gene modules are available in [Additional file 1].

Validation of mathematical model

Predicting protein activity from microarray gene expression profiles

Based on the p53 protein-DNA binding structure, we developed a nonlinear dynamic model (5) with a Hill function to represent the expression process of p53 target genes. The Hill coefficient was chosen to be 4 because p53 is in the form of tetramer as a transcription factor [22]. In addition, the proposed nonlinear model enables us to infer target genes that are negatively regulated by p53. In an earlier work, a linear model provided good estimation of p53 activities by using five known p53 target genes [10]. To evaluate the performance of our nonlinear model, we used the same p53 targets (i.e. DDB2, PA26, TNFRSF10b, p21 and Bik which are all positively regulated by p53) to predict the activities of p53. Here the time delay was assumed to be zero due to performing a consistent comparison study between the two models. Ten sets of unknown model parameters together with the p53 activities at 6 time points were estimated from each replicate of the 3 microarray experiments and also from the average of these 3 microarray time courses. Figure Figure1A1A presents the mean and 95% confidence interval of the 30 sets of the predicted p53 activities from 3 microarray experiments, and Figure Figure1B1B shows the results of the 10 predictions from the averaged time courses of 3 microarray experiments. The relative error of the estimate in Figure Figure1B1B is 2.70, which is slightly larger than both that in Figure Figure1A1A (2.70) and that obtained by the linear model (1.89). From Figure Figure1,1, we found that the new nonlinear model achieves the same goal as the linear model for predicting p53 activities.

Figure 1
Estimated p53 activity and the 95% confidence intervals based on five training genes (DDB2, PA26, TNFRSF10b, p21 and Bik) that are positively regulated by P53. (A) Estimates from the three replicates of microarray expression data. (B) Estimates from the ...

Accessing the predicted protein activity from various training genes

To determine the influence of training genes on the estimation of p53 activities, we selected various sets of 5 training genes to infer the p53 activities. Although the obtained p53 activities in one test are similar to those presented in Figure Figure1,1, in which 5 training genes [23] are negatively regulated by p53, there is slight difference between the estimated p53 activities by using different sets of training genes. One of the tests is shown in Figure Figure2,2, where the estimated p53 activities were based on 5 training genes (RAD21, CDKN3, PTTG1, MKI67 and IFITM1) that are negatively regulated by p53 [24-26]. Similar to the study presented in Figure Figure1,1, ten sets of the p53 activities were estimated from each replicate of the 3 microarray experiments and also from the average of these 3 microarray time courses. The mean and 95% confidence interval of both estimates are presented in Figures Figures2A2A and and2B,2B, respectively. The relative error of the estimate in Figure Figure2B2B is 1.28, which is very close to that in Figure Figure2A2A (1.30) but smaller than that obtained by the linear model (1.89) in Figure Figure1.1. In this case, the estimated p53 activities are very close to the measured ones. It suggests that our proposed nonlinear model is capable of making reliable predictions for the TF activities from the training genes that are all either positively or negatively regulated by the TF p53, though the dependence between the training genes and predicted TFs activities may exist.

Figure 2
Estimated p53 activity and the 95% confidence intervals based on five training genes (RAD21, CDKN3, PTTG1, MKI67 and IFITM1) that are negatively regulated by P53. (A) Estimates from the three replicates of microarray expression data. (B) Estimates from ...

Sensitivity analysis of model parameters

For the proposed nonlinear model (5), we also tested the variation of system dynamics by changing one of the four reaction rates (ci, ki, Ki, di). In this test, we used the predicted p53 activities and the corresponding model parameters to simulate the expression levels of gene DDB2 in Figure Figure3A.3A. By tuning one of the four parameters (e.g. either increasing or decreasing its value by 10%), we measured the ratio of simulation errors, defined by

equation image
Figure 3
Sensitivity analysis of the nonlinear mathematical model. (A) Ratios of the simulation errors obtained by varying one of the model parameters (index 1: parameter c; 2: k; 3: K; 4: d. Left bar: the parameter is decreased (k = 0.9k); right bar: the parameter ...

where x(12) is the microarray expression level at t = 12, x12 is the simulated expression level from the estimated model parameter, and An external file that holds a picture, illustration, etc.
Object name is 1471-2105-11-36-i2.gif is the simulated expression level from the perturbed model parameter. Figure Figure3A3A indicates that an increasing of the basal expression rate ci and a decreasing of the degradation rate di will cause considerable changes in the simulations (e.g. error ratios 3.84 and 4.19, respectively.) In addition, modification of maximal expression rate ki induces similar changes in the simulation; and a decreasing in parameter Ki causes an error ratio 1.44. Furthermore, we used the Khalil method [27] to investigate the influence of parameter variations on the system dynamics at the other time points. Simulations in Figure Figure3B3B represent the variation of system dynamics induced by a unit perturbation of model parameter, which is similar to the defined ratio (1). The results of the sensitivity analysis in Figure Figure3B3B are consistent with those in Figure Figure3A.3A. Therefore, a variation of any parameter in the proposed nonlinear model may have considerable influence on the system dynamics.

Prediction of p53 target genes

Effect of time delay in p53 target gene prediction

In order to make a new prediction rather than reproduce the published results, we used the newly inferred p53 activity in Figure Figure2B2B and the nonlinear model (5) to study the genetic regulation of p53 target genes. In the new model, the maximal possible time delay was set to 2.5 hours because the experimentally determined time delay for p53 target genes is up to 2 hours [17,28]. We used the genetic algorithm to infer the p53 mediated genetic regulation (see Methods for detailed information). In different implementations of the genetic algorithm, the additionally unknown parameter of time delay may cause the estimates to vary across a wide range of values. To reduce such parameter variation, we used a natural spline interpolation to expand the measurements from the original 7 time points to 25 time points, by adding three equidistant measurement points between each pair of measured time points. In addition, we estimated the genetic regulation twice for each gene (e.g. either with or without time delay), and selected a final regulation result which has the smallest model estimation error.

Comparison of predicted regulation states of p53 target genes across three different methods

Subsequently, both the event method [29] and correlation approach [5] were used to infer the activation/inhibition of the p53 regulation. By comparing the consistency of inferred regulation relationships among the three methods (i.e. the nonlinear model, event method and correlation method), we found that 657 and 423 of 1,312 probes from the estimation of the nonlinear model overlap with the results by the correlation method and event method, respectively. However, only 241 genes have the same p53 regulation state across all three methods. For the top 656 probes (50%) that with smaller model estimation errors, the number of overlapping probes among the three methods is reduced to 414, 265 and 166, respectively. If we reduced the probe number further by considering the top 328 genes (25%) only, then the overlapping number is reduced to 206, 130 and 80, respectively. Thus, by reducing the probe number from 1,312 to 656, the proportions of gene numbers with the same predicted p53 regulation was increased (e.g. 414:656 is greater than 657:1312). However, by reducing the probe number further to 328, we did not find such change. Therefore, in subsequent data analysis, we only focused on the top 656 (~50%) predicted genes. Among these putative p53 target genes, ~64% are positively regulated by p53 while the rest are negatively regulated. A GO functional study of these 656 putative p53 target genes indicates that ~16% of them have unknown functions and these genes are excluded from our further study.

Binding motif information of predicted p53 target genes

To provide more criteria for identifying putative p53 target genes, we searched for the p53 binding motif on the upstream non-coding region of the top 656 genes. This is because a physical interaction between p53 and its targets is essential for its role as a controller of the genetic regulation [1]. Particularly, p53 has a well documented 10 bp consensus binding motif (RRRCWWGYYY) and a DNA sequence with two copies of such monomer is strongly bound by the p53 protein [1]. Thus, for each putative target, we extracted the corresponding 10 kb DNA sequences located directly upstream of the transcription start site from Refs [30]. Among the 656 putative p53 target genes, we found the upstream DNA sequences for 511 of them. Then a motif discovery program MatrixREDUCE [31] was applied to search for the p53 consensus binding site. The results indicate that ~72.0% (366 out of 511 genes) of putative p53 targets have at least 2 copies of the p53 binding motif (perfect match counts of p53 binding site), while only ~10% (47 out of 511 genes) and ~20% (98 out of 511 genes) of them have zero and one p53 monomer, respectively. Based on the model estimation error and upstream TF-binding information of the 656 putative p53 target genes, we further narrowed down the number of possible p53 targets. In addition, for any gene that has more than one probe, we chose only the probe that has the smallest estimation error. We also excluded genes with very small parameter ki in model (5) because p53 may not have much influence on them [10]. A final list containing ~317 putative p53 targets [Additional file 2] covers around ~24% of the total studied probes (~1312). Table Table22 presents 50 of these predicted putative p53 target genes.

Table 2
Putative p53 target genes predicted by our method.

Discrepancies between different predictions

It is interesting to explore whether the putative p53 target genes identified above correspond to sets that have been discovered by other methods. For that reason, we collected four lists of putative p53 targets from different studies. They are 45 unique genes from 50 predicted p53 target probes which were obtained by applying the linear HVDM method on the Affymetrix microarray time-series data [10]; 317 unique genes which were detected by applying our non-linear dynamic model on the above same dataset; 76 unique genes which were identified by analysing p53-regulated gene expression profiles of oligonucleotide arrays [17]; and 205 unique genes which were suggested by Chip-PET analysis of human genome-wide p53 transcription-factor binding sites [19]. As shown in Table Table3,3, the overlapping among the different predictions is quite poor.

Table 3
The number of overlapping genes between the predicted putative p53 targets from the MVDM method [10], gene expression analysis (GRA) [17], Chip-PET analysis [19] and our nonlinear model in this work.

Target gene bias from microarray datasets

To find out the reason for these discrepancies, we examined the 76 target genes that were identified in reference [17]. Among these 76 target genes, 31 of them were firstly removed in our pre-processing step due to the weak signals, bad quality or less variation across all time points. Secondly, another 31 of them were removed in the later selection of the most relevant response probes by using the Fisher's linear discriminant method because of their weak response to the ionizing radiation. In the end, only 14 of the 76 genes were entered into our nonlinear model and we finally identified 10 of them as our putative p53 target genes (e.g. CDKN1A, MST1 and BIRC5 in [Additional file 2]). The remaining 4 genes such as HSD17B1 were not included in our prediction because of the relatively large model estimation errors. The large errors may be a by-product of the noise in the microarray gene expression data.

Target gene bias from inference models

We also investigated the 50 putative target genes that were provided by the linear model [10]. First of all, 48 of them were included in the top 15% of the most relevant response probes (~1,312 probes). Secondly, 36 of them were within the top 50% of the 1,312 probes and we removed 12 genes due to the relatively larger model estimation errors. Finally, we further discarded probes with duplicate gene names (~2) and genes without p53 binding site on the regulatory region (~7). Therefore in the final list in [Additional file 2], we presented only 27 of the remaining 36 genes. Figure Figure44 shows both the predicted and measured expression profiles of 4 genes which were selected in reference [10]. Taken together, we conclude that the discrepancy of p53 target gene predictions among various studies may be mainly caused by either pre-processing of microarray data or condition-specific gene regulation.

Figure 4
Expression profiles of four p53 target genes that were identified by the HVDM method. (A) Gene DENND2D (probe ID 221081_S_AT) was also predicted in this work. (B) Gene RRM1 has two probe set ID 201477_S_AT (dash-line, predicted by the HVDM method) and ...

In silico validation of putative p53 targets

Although a wet lab experiment may be the best way to validate the whole list of predictions, other external information such as DNA sequence analysis could be used to support the computational predictions [32]. For example, we found ~80% of the top 317 putative p53 targets have at least 2 perfect matches of p53 consensus sequences (RRRCWWGYYY) on the 10 Kb upstream region. This may support the hypothesis that the predicted target genes may be strongly bound by p53 in vivo [1]. A short list of these p53 target genes is shown in Table Table2,2, where we found many known p53 target genes including p21, Bax, Bik and Mdm2. However, a number of the top ranked putative target genes, such as the 4 genes (RPS19, RPL38, RPS27L, and RPL37A) that encode ribosomal proteins and several major histocompatibility complex genes (e.g. HLA-C and HLA-B), seem to have no obvious connection to p53. These ribosomal proteins have been shown to activate p53 by inhibiting oncoprotein MDM2, leading to inhibition of cell cycle progression [33]. Thus, the ribosomal proteins can regulate the p53-MDM2 feedback loop in response to different stresses and provide a general pathway for p53 activation from perturbation of ribosome biogenesis. For major histocompatibility complex genes, they are involved in the major histocompatibility complex (MHC) class I antigen presentation pathway which plays a key role in host tumour surveillance. Experimental data suggest that p53 activates the MHC class I pathway by inducing TAP1, which would assist the process [34].

Protein binding motif analysis for putative p53 target genes

Binding site distribution of putative p53 target genes

The lack of common p53 targets among four different predictions generated a few interesting questions to us. Will the four lists of putative p53 targets share the same p53 binding motif distribution on the upstream non-coding region? Will the genes predicted from these four studies share the same functional categories too? To answer these questions, we collected the p53 binding motif counts on the gene upstream regions for the four predictions and listed the results in Table Table4.4. It indicates that putative targets predicted by the gene expression analysis, the Chip-PET analysis, and our nonlinear model, share a similar p53 binding preference. For example, there is an even distribution (~20%) of zero, one, two, and more than two p53 binding sites on the 5 kb region. However, there are more p53 binding motifs on the 10 kb upstream region than those on the 5 kb region. In addition, ~46-58% of putative p53 targets have more than two p53 binding sites on the 10 kb upstream region but only ~16-20% of targets have multiple binding sites on the 5 kb region. Furthermore, less than 10% of targets do not have p53 binding sites on the 10 kb region. The similar binding preference among various predictions suggests that the majority of putative p53 targets (~70%) may be directly controlled by remote p53 transcription factors but less than 30% of them may be the second effect targets.

Table 4
Comparison of the p53 consensus motif distributions in the four sets of putative p53 target genes obtained by the MVDM method [10], gene expression analysis [17], Chip-PET analysis [19] and our nonlinear model in this work.

Functional analysis of putative p53 target genes

A functional analysis of above four lists of putative p53 targets also reveals interesting information such as the fact that all works identified the same core biological functions of p53 (e.g. cell cycle, cell death, cell proliferation and response to DNA damage stimulus). However, there are a few gene functional categories that were only predicted by individual studies. For example, the lists from the gene expression analysis and Chip-PET analysis contain blood coagulation, body fluids, response to wound, muscle and signal transduction genes. However, only the list from the Chip-PET analysis is enriched by cell motility, cell localization and enzyme activity genes. In addition, high enrichment of metabolism, biosynthetic process and immune system process exclusively appear in our prediction. Although our results indicate that most of the p53 targets share the same p53 binding preference, their functional roles are conditionally specific and their biological functions span to various functional categories with the dependence of intrinsic and extrinsic conditions. The functional differences among the four lists of putative p53 targets may partially explain the reason for the poor overlapping among them. In addition, the poor overlapping may be caused by the putative p53 target genes that were induced by different types of event such as different cell types or different treatments of p53 regulation. For example, the target genes identified by microarray time-series data [10] was under γ-irradiated Human MOLT4 cells; but the target genes predicted from oligonucleotide arrays [17] and ChIP-PET analysis [19] were induced by zinc-induced p53 in EB-1 cells and 5-fluorouracil treated HCT116 cells, respectively. Thus, the results suggest that the nature of p53 response is conditionally dependent. Different experiments form distinct sets of putative target genes and a subset with a few target genes in common to all p53 responses [17].

Combinational regulation of putative p53 target genes

Furthermore, we looked for the potential p53 co-regulators on the upstream non-coding region of the putative p53 target genes. By collecting 409 weight matrixes of human transcription-factors, which represent 254 unique human TFs from the TRANSFAC database [35], and transforming the weight matrices to the position-specific affinity matrices, we used the MatrixREDUCE program [31] to compute the transcription factor binding affnities on the upstream of all putative p53 targets [Additional file 3]. A clustering analysis of the relative sequence affinity profiles for human TFs was also performed [Additional file 4], which suggests the predicted sequence signals of several human TFs are either commonly enriched or depleted in all targets related to the expected occurrence on random sequences. For instance, the top two most depleted sequence signals are E2F and CREB, which rarely appear on the 10 k upstream region of all putative p53 target genes. It suggests that these two TFs may not directly interact with p53 target genes. Such hypothesis is consistent with the literature information, which claims that both E2F and CREB often interact with other proteins directly and form a protein complex to regulate the transcriptional activity (e.g. the E2F-p53 complex stimulates the apoptotic function of p53 [36] and CREB modulates p53 by acetylation [37]). On the other hand, the top three most enriched sequence affnities on 10 kb upstream region for putative p53 targets are PITX2, FOXO1 and TBP, which are all known to be related to functional regulation of p53. PITX2 can bind to HPV E6 protein and inhibit E6/E6AP-mediated p53 degradation [38]. FOXO1 may function as a tumour suppressor and regulators of FOXO1 function are controlled by p53 [39]. TBP is a TATA-binding protein but p53 can prevent TBP from participating in RNA pol III-dependent transcription [40]. Thus, p53 response genes may preserve certain sequence specific features (e.g. a common cis-regulatory module on the upstream region) that enables p53 to interact easily with other co-regulators to control diverse biological processes.


This work developed a nonlinear model for inferring genetic regulation from microarray gene expression data. The major feature of this approach is the inclusion of the cooperative binding of TFs by which we can study the nonlinear properties of gene expression in a sophisticated way. It is also a practical approach to investigate the impact of time delay of gene expression on the dynamics of the down-stream target genes. We validated the proposed method by comparing the estimated TF p53 activities with experimental data. In addition, the predicted putative p53 target genes by our nonlinear model were supported by DNA sequence analysis which suggests that p53 predominately controls remote genes. The long-distance gene regulation may be accomplished by a cooperative regulation between p53 and other proteins. This hypothesis may also explain the poor overlap among the four lists of the putative p53 target genes, and support the fact that we could not find a p53 binding motif on the upstream non-coding region of at least 20% of the putative p53 targets although these genes may be strongly positively regulated by p53 protein [10].

For issues regarding the estimation of protein activities and the effects of time delay in genetic regulation, we first emphasize that gene transcription depends on multiple factors such as the activities of transcription factors, the availability of RNA polymerase and the activities of other promoters in the transcriptional machinery. For example, in order to activate gene expression, the required availability of RNAP II and other promoters differ significantly between two p53 target genes - p21 and Fas/AOP1 [28]. However, most modelling approaches including our current study approximate the activities of all the promoters in the transcriptional machinery as the activities of TF p53. Therefore, our estimated p53 activities represent the total activities of all factors in the transcriptional machinery, which may be slightly different from one another if various sets of training target genes were used. In addition, time delay exists in many biological processes of gene expression such as transcriptional initiation, elongation, protein translocation, and translational elongation. However, in the present model, we simplified all kinds of time delay effects into a single factor. This is a practical approach to study the time delay effect of each individual p53 target gene, and therefore the time delay of each gene may differ.

Finally, a number of factors may contribute to the variation of predictions using the mathematical model. For example, we have shown that the selection of training genes may influence the estimation of p53 activity and consequently alter the prediction of putative target genes. In addition, the proposed nonlinear differential equation model may affect the estimation of putative target genes. The present model estimation error is related to the selection of synthesis function. Although the Michaelis-Menten function is generally used if there is no extra information about the TFs, more precise estimates may be obtained by using a more sophisticated synthesis function which requires TFs' cooperative binding and/or binding sites information. Furthermore, in the present work the relative error was used to compare the errors of different genes. Nevertheless, the model estimation error may be large if the gene expression is weak. For that reason, a number of discovered p53 target genes were not included in our prediction, even though their simulations matched well the gene expression profiles (Figure (Figure4D).4D). Thus, it is worthy to evaluate the influence of the error measurement on both the predictions of the TF activities and genetic regulation to the putative target genes. In that case, other error measurement methods (e.g. the weighted distance measure [41]) may be considered. Finally, it is widely recognized that microarray gene expression data is noisy. It is therefore important to develop stochastic models and the corresponding stochastic inference methods [42] to investigate the impact of gene expression noise on the accuracy of the modelling inference.


In summary, we have developed a nonlinear model for inferring genetic regulation from microarray gene expression data. This "bottom-up" method was designed not only to infer the regulation relationship between TF and its down-stream genes but also to estimate the up-stream protein activities based on the expression levels of the target genes. The successful prediction of a large number of putative p53 target genes indicates that the proposed dynamic model is a promising method to investigate genetic regulation. It is expected that our results will provide both valuable prediction for further experimental validation and quantitative information for the development of the p53 gene regulatory networks.


Microarray data analysis

This research is based on a published microarray dataset which was generated from the Human All Origin, MOLT4 cells carrying wild-type p53. Cell were γ-irradiated and harvested every 2 hours over a 12-hours period [10]. We obtained the ionizing radiation Affymetrix dataset [10] from ArrayExpress (E-MEXP-549). Firstly, the microarray dataset was pre-processed by an R BioConduct package [43], in which probes with bad signal quality and less variation across all the time points were removed. This resulted in ~8,737 probes from a total of 22,284 probes. The pre-processed probes were then further median centred within each array and transformed to Z-scores before using the pair-wise Fisher's linear discriminant method [20] to screen probes with the most relevant response to ionizing radiation. The top 15% of the most relevant response probes (~1,312 probes) were selected as the input data to our nonlinear model. All gene symbols were obtained from the NETAFFX [44]. It is noteworthy that 2 of 50 putative p53 target probes (201714_at and 220623_s_at) from Refs [10] are not included in the selected 1,312 probes.

Nonlinear model

A mathematical model with a general type of the cis-regulatory functions has been proposed recently aimed at reconstructing genetic regulatory networks [12,13]. The model includes both positive and negative regulation, time delay and number of DNA-binding sites. However, the cooperative binding of TFs was not considered. In this work, we propose a new model where the dynamics of gene transcription is represented as

equation image

where ci is the basal transcriptional rate, ki is the maximal expression rate and di is the degradation rate. Here we use one value τij to represent regulatory delays of gene j related to the expression of gene i. The cis-regulatory function fi(xj,..., xk) includes both positive and negative regulations, given by

equation image

and An external file that holds a picture, illustration, etc.
Object name is 1471-2105-11-36-i5.gif and An external file that holds a picture, illustration, etc.
Object name is 1471-2105-11-36-i6.gif are subsets of positive and negative regulations of the total regulation set R, respectively.

For each TF, the regulation is realized by

equation image

where m is the number of DNA-binding site and n represents the cooperative binding of the TF. The present model is a more general approach which includes the proposed cis-regulatory function model when n = 1 [12,13], the Michaelis-Menten function model when m = n = 1 [11], and the Hill function model when n > 1. Based on the structure of TF p53, the transcription of a p53 target gene is represented by

equation image

where xi(t) is the expression level of gene i and p(t) is the p53 activity at time t. Here δi is an indicator of the feedback regulation, namely δi = 0 if p53 inhibit the transcription of gene i or δi = 1 if the transcription is induced by p53. The Hill coefficient was chosen to be 4 since p53 is in the form of tetramer as a transcriptional factor [22].

Prediction of TF activities

It is assumed that a TF regulates the expression of N target genes. The proposed mathematical model (2) can be used to infer the activities of the TF from the expression levels of these N target genes. To achieve this, we developed a system of N differential equations. Each equation of the system follows the model (2) and represents the expression process of a specific gene. This system contains a number of unknown parameters including the kinetic rates (ci, ki, di, τij) (i = 1, ..., N) together with the TF activities at M measurement time points (t1,..., tM). Using an optimization method such as the genetic algorithm [45], we can search the optimal model parameters to match the expression levels {xij, i = 1,..., N, j = 1, ..., M} of these N target genes at M measurement time points of the microarray experiments. The estimated TF activities from the optimization method is the prediction of the TF activities.

Specifically, this work used the nonlinear model (5) to predict the p53 activities from a set of five training target genes (N = 5). Here a system of five equations, in which each equation follows the same nonlinear model (5) with different parameters, was used to represent the expression of five training genes. The unknown parameters of the system are rate constants (ci, ki, Ki, di, τi, δi) (i = 1,..., 5) and p53 activities (pj = p(tj), tj = 2, 4,..., 12) at six time points. The activities of p53 at other time points will be obtained by the natural spline interpolation. In total, there are 26 unknown parameters in the system and the p53 activities at 6 time points is our final inference result.

We used a MATLAB toolbox of the genetic algorithm [45] to search the optimal values of these 26 parameters. The search space of each parameter is [0, WMAX] and the values of WMAX are [5, 5, 5, 2] for [ci, ki, Ki, di]. For p53 activity pi, the values of WMAX are unit one. After a set of unknown parameters is created by the genetic algorithm, a program developed in MATLAB was used to simulate the nonlinear system of 5 equations and calculate the objective value. The program is described below.

1. Create an individual of p53 activities (pi, i = 1,...,6) and regulatory parameters (ci, ki, Ki, di) (i = 1, ..., 5) from the genetic algorithm;

2. Use the natural spline interpolation to calculate p53 activities at time points in [0, 12];

3. Solve the system of 5 equations (5) by using the 4-th order classic Runge-Kutta method for each training gene i from the initial expression level ui0 (= xi0), and find the simulated levels uij(j = 1,..., 6);

4. Calculate the estimation error of gene i as An external file that holds a picture, illustration, etc.
Object name is 1471-2105-11-36-i9.gif, where xij is the microarray expression level. Finally, the objective value is An external file that holds a picture, illustration, etc.
Object name is 1471-2105-11-36-i10.gif.

Prediction of putative target genes

Using the predicted TF activities in the previous subsection, we can infer the TF-mediated genetic regulation based on the proposed nonlinear model (2). The genetic algorithm can be used here to search the optimal model parameters in functions (3) and (4) to match the expression level of a putative target gene and examine whether the positive or negative regulation in function (3) is more appropriate to present the genetic regulation. All the genes considered will be ranked by the model error that is defined as the difference between the simulated expression levels from model (2) and microarray expression profiles. Genes with smaller model error will be selected as the putative target genes and further research will be carried out for these genes.

Specifically, we used the newly inferred p53 activity in Figure Figure2B2B and nonlinear model (5) to infer the genetic regulation of p53 target genes. There are six unknown parameters for each gene's regulation, namely ci, ki, Ki, di, τi and δi. The genetic algorithm was used to search for the optimal values of these six parameters. The value of δi is determined by another parameter ηi whose search area is [-1, 1]; and parameter ηi indicates either positive (ηi > 0, δi = 1) or negative (ηi < 0, δi = 0) regulation from p53. The time delay τi is treated as one of the unknown parameter and its value will be searched by the genetic algorithm. Ten estimates (cij, kij, Kij, dij, τij, δij) (j = 1, ..., 10) were obtained from different implementations of the genetic algorithm. From these 10 estimates, we selected the set of parameters that has the smallest estimation error as the final estimate. The following algorithm was developed to estimate the model parameters.

1. Create an individual of the regulatory parameter (ci, ki, Ki, di, τi, δi) from the genetic algorithm;

2. Determine the value of δi in Equation (5). If ηi > 0, δi = 1. Otherwise δi = 0;

3. Determine the p53 activities based on activities in Figure Figure2B2B and the time delay τi. p(t - τi) = 0 (t τi).

4. Simulate model (5) by using the initial level ui0(= xi0) and find the simulated expression levels uij (j = 1,..., m);

5. Calculate the objective value An external file that holds a picture, illustration, etc.
Object name is 1471-2105-11-36-i11.gif.

Sensitivity analysis

Here we use the Khalil method [27] for sensitivity analysis of mathematical models. For a given model (the base model) with parameter p

equation image

we consider the solution x* of this system with a perturbed parameter p + Δp. The difference between solutions x* and x is

equation image

Together with the base model (6), the adjacent model for parameter p is

equation image

Here Ep represents the drift of the solution with a unit parameter perturbation. The solutions of the adjacent models for certain important parameters in the base model give insight into which parameter induces the largest error in solutions and when errors will be the largest in simulations.

Authors' contributions

TT developed the mathematical model, carried out simulation and inference, and identified p53 target genes. JW analyzed the Microarray expression data, identified p53 target genes and analyzed the binding motif. Both authors wrote the paper and approved the final manuscript.

Supplementary Material

Additional file 1:

A complete list of 1,312 selected gene probes. Here we listed the 1,312 most relevant response probes to ionizing radiation based on the selection of Fisher's linear distriminant. These probes were further assigned to 40 clusters according to their expression profiles across all time points. The detailed information of each probe includes Gene title, GO information, nonlinear model estimation errors, gene regulation state, time delay effect, gene regulation state based on event method or correlation methods.

Additional file 2:

Detailed information for the top 317 putative p53 target genes. Here we list the putative p53 target gene information (i.e. AffyProbe ID, gene symbol and gene title), quantitative model estimation error, target gene regulation state inferred by quantitative model (regulate: 1 represents positive regulation by p53 but -1 represents negative regulation by p53), time delay effect (delay: hour), target gene regulation state inferred by event method (event score > 0 represents positive regulation, event sore < 0 represents negative regulation), target gene regulation state inferred by correlation method (correlation coefficient > 0 represents positive regulation, correlation coefficient < 0 represents negative regulation), and the number of motif count of perfect match of 10-mer p53 binding motif on 10 kb upstream region (motif counts).

Additional file 3:

Predicted TF affinity profiles for four lists of putative p53 target genes. Here we used MatrixREDUCE program to compute sequence affinity profiles for 409 human TF weight matrices on four lists of p53 target genes. An average sequence affinity of each TF on each list is listed below according to their prediction methods such as MBDM method, nonlinear quantitative model, microarray gene expression analysis, and Chip-PET analysis, respectively. The corresponding affinity score for random sequences and its associated relative ratio to each list are presented as well.

Additional file 4:

Hierarchical clustering of relative sequence affinity ratios. Here we present results of hierarchical clustering of relative sequence affinity ratios for 409 human TFs across four list of putative p53 target genes. Yellow colour represents enriched TFs but blue colour represents depleted TFs.


We thank Professor Ben Davidson for his critical reading of our manuscript. Junbai Wang is supported by Norwegian Cancer Society and NOTUR project.


  • el Deiry WS, Kern SE, Pietenpol JA, Kinzler KW, Vogelstein B. Definition of a consensus binding site for p53. Nat Genet. 1992;1:45–49. doi: 10.1038/ng0492-45. [PubMed] [Cross Ref]
  • Liao JC, Boscolo R, Yang YL, Tran LM, Sabatti C, Roychowdhury VP. Network component analysis: Reconstruction of regulatory signals in biological systems. Proc Natl Acad Sci (USA) 2003;100(26):15522–15527. doi: 10.1073/pnas.2136632100. [PMC free article] [PubMed] [Cross Ref]
  • Wang J, Cheung LW, Delabie J. New probabilistic graphical models for genetic regulatory networks studies. J Biomed Inform. 2005;38(6):443–455. doi: 10.1016/j.jbi.2005.04.003. [PubMed] [Cross Ref]
  • Sun N, Carroll RJ, Zhao H. Bayesian error analysis model for reconstructing transcriptional regulatory networks. Proc Natl Acad Sci (USA) 2006;103(21):7988–7993. doi: 10.1073/pnas.0600164103. [PMC free article] [PubMed] [Cross Ref]
  • Wang J. A new framework for identifying combinatorial regulation of transcription factors: A case study of the yeast cell cycle. J Biomed Inform. 2007;40(6):707–725. doi: 10.1016/j.jbi.2007.02.003. [PubMed] [Cross Ref]
  • de Jong H. Modelling and simulation of genetic regulatory systems: A literature review. J Comput Biol. 2002;9:67–103. doi: 10.1089/10665270252833208. [PubMed] [Cross Ref]
  • Vu TT, Vohradsky J. Nonlinear differential equation model for quantification of transcriptional regulation applied to microarray data of Saccharomyces cerevisiae. Nucleic Acids Res. 2007;35:279–287. doi: 10.1093/nar/gkl1001. [PMC free article] [PubMed] [Cross Ref]
  • Yeung MK, Tegner J, Collins JJ. Reverse engineering gene networks using singular value decomposition and robust regression. Proc Natl Acad Sci (USA) 2002;99(9):6163–6168. doi: 10.1073/pnas.092576199. [PMC free article] [PubMed] [Cross Ref]
  • Gardner TS, di Bernardo D, Lorenz D, Collins JJ. Inferring genetic networks and identifying compound mode of action via expression profiling. Science. 2003;301(5629):102–105. doi: 10.1126/science.1081900. [PubMed] [Cross Ref]
  • Barenco M, Tomescu D, Brewer D, Callard R, Stark J, Hubank M. Ranked prediction of p53 targets using hidden variable dynamic modeling. Genome Biol. 2006;7(3):R25. doi: 10.1186/gb-2006-7-3-r25. [PMC free article] [PubMed] [Cross Ref]
  • Rogers S, Khanin R, Girolami M. Bayesian model-based inference of transcription factor activity. BMC Bioinformatics. 2007;8(Suppl 2):S2. doi: 10.1186/1471-2105-8-S2-S2. [PMC free article] [PubMed] [Cross Ref]
  • Goutsias J, Kim S. Stochastic transcriptional regulatory systems with time delay: a mean-field approximation. J Comput Biol. 2006;13(5):1049–1076. doi: 10.1089/cmb.2006.13.1049. [PubMed] [Cross Ref]
  • Goutsias J, Kim S. A nonlinear discrete dynamical model for transcriptional regulation: Construction and properties. Biophy J. 2004;86(4):1922–1945. doi: 10.1016/S0006-3495(04)74257-5. [PMC free article] [PubMed] [Cross Ref]
  • Joyce AR, Palsson BO. The model organism as a system: integrating 'omics' data set. Nat Rev Mol Cell Bio. 2006;7(3):198–210. doi: 10.1038/nrm1857. [PubMed] [Cross Ref]
  • Wang J. Computational biology of genome expression and regulation-a review of microarray bioinformatics. J Environ Pathol Toxicol Oncol. 2008;27(3):157–179. [PubMed]
  • Vousden KH, Lu X. Live or let die: the cell's response to p53. Nat Rew Cancer. 2002;2(8):594–604. doi: 10.1038/nrc864. [PubMed] [Cross Ref]
  • Zhao RB, Gish K, Murphy M, Yin YX, Notterman D, Hoffman WH, Tom E, Mack DH, Levine AJ. Analysis of p53-regulated gene expression patterns using oligonucleotide arrays. Genes Deve. 2000;14(8):981–993. [PMC free article] [PubMed]
  • Rahman-Roblick R, Roblick UJ, Hellman U, Conrottp P, Liu T, Becker S, Hirschberg D, Jornvall H, Auer G, Wiman KG. 53 targets identified by protein expression profiling. Proc Natl Acad Sci (USA) 2007;104(13):5401–5406. doi: 10.1073/pnas.0700794104. [PMC free article] [PubMed] [Cross Ref]
  • Wei CL, Wu Q, Vega VB, Chiu KP, Ng P, Zhang T, Shahab A, Yong HC, Fu Y, Weng Z, Liu J, Zhao XD, Chew JL, Lee YL, Kuznetsov VA, Sung WK, Miller LD, Lim B, Liu ET, Yu Q, Ng HH, Ruan Y. A global map of p53 transcription-factor binding sites in the human genome. Cell. 2006;124:207–219. doi: 10.1016/j.cell.2005.10.043. [PubMed] [Cross Ref]
  • Wang J, Bo TH, Jonassen I, Myklebost O, Hovig E. Tumor classification and marker gene prediction by feature selection and fuzzy c-means clustering using microarray data. BMC Bioinformatics. 2004;4:60. doi: 10.1186/1471-2105-4-60. [PMC free article] [PubMed] [Cross Ref]
  • Conesa A, Nueda MJ, Ferrer A, Talon M. maSigPro: a method to identify significantly differential expression profiles in time-course microarray experiments. Bioinformatics. 2006;22(9):1096–1102. doi: 10.1093/bioinformatics/btl056. [PubMed] [Cross Ref]
  • Ma L, Wagner J, Rice JJ, Hu W, Levine AJ, Stolovitzky GA. A plausible model for the digital response of p53 to DNA damage. Proc Natl Acad Sci (USA) 2005;102(40):14266–14271. doi: 10.1073/pnas.0501352102. [PMC free article] [PubMed] [Cross Ref]
  • Spurgers KB, Gold DL, Coombes KR, Bohnenstiehl NL, Mullins B, Meyn RE, Logothetis CJ, McDonnell TJ. Identification of cell cycle, regulatory genes as principal targets of p53-mediated transcriptional repression. J Biol Chem. 2006;281(35):25134–25142. doi: 10.1074/jbc.M513901200. [PubMed] [Cross Ref]
  • Kho PS, Wang Z, Zhuang L, Li Y, Chew JL, Ng HH, Liu ET, Yu Q. p53-regulated Transcriptional Program Associated with Genotoxic Stress-induced Apoptosis. J Biol Chem. 2004;279(20):21183–21192. doi: 10.1074/jbc.M311912200. [PubMed] [Cross Ref]
  • Wu Q, Kirschmeier P, Hockenberry T, Yang TY, Brassard DL, Wang L, McClanahan T, Black S, Rizzi G, Musco ML, Mirza A, Liu S. Transcriptional regulation during p21WAF1/CIP1-induced apoptosis in human ovarian cancer cells. J Biol Chem. 2002;277(39):36329–36337. doi: 10.1074/jbc.M204962200. [PubMed] [Cross Ref]
  • Bhonde MR, Hanski ML, Budczies J, Cao M, Gillissen B, Moorthy D, Simonetta F, Scherübl H, Truss M, Hagemeier C, Mewes HW, Daniel PT, Zeitz M, Hanski C. DNA damage-induced expression of p53 suppresses mitotic checkpoint kinase hMps1: the lack of this suppression in p53MUT cells contributes to apoptosis. J Biol Chem. 2006;281(13):8675–8685. doi: 10.1074/jbc.M511333200. [PubMed] [Cross Ref]
  • Erb RS, Michaels GS. Sensitivity of biological models to errors in parameter estimates. Pac Sympos Biocomp. 1999;4:53–64. [PubMed]
  • Espinosa JM, Verdun RE, Emerson BM. P53 functions through stress - and promoter-specific recruitment of transcription initiation components before and after DNA damage. Mol Cell. 2003;12(4):1015–1027. doi: 10.1016/S1097-2765(03)00359-9. [PubMed] [Cross Ref]
  • Kwon AT, Hoos HH, Ng R. Inference of transcriptional regulation relationships from gene expression data. Bioinformatics. 2005;19(8):905–912. doi: 10.1093/bioinformatics/btg106. [PubMed] [Cross Ref]
  • Aach J, Bulyk ML, Church GM, Comander J, Derti A, Shendure J. Computational comparison of two draft sequences of the human genome. Nature. 2001;409(6822):856–859. doi: 10.1038/35057055. [PubMed] [Cross Ref]
  • Moorman C, Sun LV, Wang J, de Wit E, Talhout W, Ward LD, Greil F, Lu XJ, White KP, Bussemaker HJ, van Steensel B. Hotspots of transcription factor colocalization in the genome of Drosophila melanogaster. Proc Natl Acad Sci (USA) 2006;103(32):12027–12032. doi: 10.1073/pnas.0605003103. [PMC free article] [PubMed] [Cross Ref]
  • Liu S, Seidel-Dugan C. In search of p53 target genes for the therapeutic manipulation of cancer. Curr Opin Drug Discov Devel. 2006;9(2):176–183. [PubMed]
  • Chen D, Zhang Z, Li M, Wang W, Li Y, Rayburn ER, Hill DL, Wang H, Zhang R. Ribosomal protein S7 as a novel modulator of p53-MDM2 interaction: binding to MDM2, stabilization of p53 protein, and activation of p53 function. Oncogene. 2007;26(35):5029–5037. doi: 10.1038/sj.onc.1210327. [PubMed] [Cross Ref]
  • Zhu K, Wang J, Zhu J, Jiang J, Shou J, Chen X. P53 induces TAP1 and enhances the transport of MHC class I peptides. Oncogene. 1999;18(54):7740–7747. doi: 10.1038/sj.onc.1203235. [PubMed] [Cross Ref]
  • Wingender E, Dietze P, Karas H, Knuppel R. TRANSFAC: a database on transcription factors and their DNA binding sites. Nucleic Acids Res. 1996;24:238–241. doi: 10.1093/nar/24.1.238. [PMC free article] [PubMed] [Cross Ref]
  • Braithwaite AW, Del Sal G, Lu X. Some p53-binding proteins that can function as arbiters of life and death. Cell Death Differ. 2006;13(6):984–993. doi: 10.1038/sj.cdd.4401924. [PubMed] [Cross Ref]
  • Karamouzis MV, Konstantinopoulos PA, Papavassiliou AG. Roles of CREB-binding protein (CBP)/p300 in respiratory epithelium tumorigenesis. Cell Res. 2007;17(4):324–332. doi: 10.1038/cr.2007.10. [PubMed] [Cross Ref]
  • Wei Q. Pitx2a binds to human papillomavirus type 18 E6 protein and inhibits E6-mediated P53 degradation in HeLa cells. J Biol Chem. 2005;280(45):37790–37797. doi: 10.1074/jbc.M502974200. [PMC free article] [PubMed] [Cross Ref]
  • Sedding DG. FoxO transcription factors in oxidative stress response and ageing-a new fork on the way to longevity? Biol Chem. 2008;389(3):279–283. doi: 10.1515/BC.2008.033. [PubMed] [Cross Ref]
  • Johnson SA, Dubeau L, White RJ, Johnson DL. The TATA-binding protein as a regulator of cellular transformation. Cell Cycle. 2003;2(5):442–444. [PubMed]
  • Moles CG, Mendes P, Banga JR. Parameter estimation in biochemical pathways: A comparison of global optimization methods. Genome Res. 2003;13(11):2467–2474. doi: 10.1101/gr.1262503. [PMC free article] [PubMed] [Cross Ref]
  • Tian T, Xu S, Gao J, Burrage K. Simulated maximum likelihood method for estimating kinetic rates in genetic regulation. Bioinformatics. 2007;23:84–91. doi: 10.1093/bioinformatics/btl552. [PubMed] [Cross Ref]
  • Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, Ellis B, Gautier L, Ge Y, Gentry J, Hornik K, Hothorn T, Huber W, Iacus S, Irizarry R, Leisch F, Li C, Maechler M, Rossini AJ, Sawitzki G, Smith C, Smyth G, Tierney L, Yang JY, Zhang J. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol. 2004;5(10):R80. doi: 10.1186/gb-2004-5-10-r80. [PMC free article] [PubMed] [Cross Ref]
  • Liu G, Loraine AE, Shigeta R, Cline M, Cheng J, Valmeekam V, Sun S, Kulp D, Siani-Rose MA. NetAffx: Affymetrix probesets and annotations. Nucleic Acids Res. 2003;31:82–86. doi: 10.1093/nar/gkg121. [PMC free article] [PubMed] [Cross Ref]
  • Chipperfield A, Fleming PJ, Pohlheim H. A Genetic Algorithm Toolbox for MATLAB. Proc Int Conf Sys Engineering. 1994. pp. 200–207.

Articles from BMC Bioinformatics are provided here courtesy of BioMed Central


Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC


  • MedGen
    Related information in MedGen
  • PubMed
    PubMed citations for these articles

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...